CPCLIN - Centro de Pesquisas Clínicas /ID# 207493

São Paulo 01228-200

0 studies enrolling now · 1 studies all time

What they study most

Psoriatic Arthritis

Studies at this site

• A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy — Running, not enrolling